相关实验视频

Updated: Jun 29, 2025

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.3K

在小鼠中,类固醇诱导的眼睛高血压通过选择性EP2,EP3,EP4和IP前列腺素受体激活剂以不同的方式降低

Najam A Sharif1,2,3,4,5,6,7,8, J Cameron Millar8, Gulab Zode9

  • 1Ophthalmology Innovation Center, Santen Inc., Emeryville, CA 94608, USA.

International journal of molecular sciences
|March 28, 2024
PubMed
概括

在小鼠模型中,五种前列腺素受体激活剂降低了眼内压力. 像mizoprostol和PF-04217329这样的EP2选择性激动剂证明了治疗眼睛高血压的最有效的IOP降低.

关键词:
布塔前列腺是什么意思?作为EP2受体的激动剂.IOPOP IOPOP IOPOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOP IOPPF-0421732929 的时间是什么?眼睛的高血压,眼睛的高血压类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型: 类型:

更多相关视频

A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice09:03

A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice

Published on: November 15, 2019

9.9K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.1K

相关概念视频

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
440
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
173